Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome
Open Access
- 16 February 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (7), 3024-3029
- https://doi.org/10.1073/pnas.0914865107
Abstract
DNA ligase IV (LIG4) is an essential component of the nonhomologous end-joining (NHEJ) repair pathway and plays a key role in V(D)J recombination. Hypomorphic LIG4 mutations in humans are associated with increased cellular radiosensitivity, microcephaly, facial dysmorphisms, growth retardation, developmental delay, and a variable degree of immunodeficiency. We have generated a knock-in mouse model with a homozygous Lig4 R278H mutation that corresponds to the first LIG4 mutation reported in humans. The phenotype of homozygous mutant mice Lig4R278H/R278H (Lig4R/R) includes growth retardation, a decreased life span, a severe cellular sensitivity to ionizing radiation, and a very severe, but incomplete block in T and B cell development. Peripheral T lymphocytes show an activated and anergic phenotype, reduced viability, and a restricted repertoire, reminiscent of human leaky SCID. Genomic instability is associated with a high rate of thymic tumor development. Finally, Lig4R/R mice spontaneously produce low-affinity antibodies that include autoreactive specificities, but are unable to mount high-affinity antibody responses. These findings highlight the importance of LIG4 in lymphocyte development and function, and in genomic stability maintenance, and provide a model for the complex phenotype of LIG4 syndrome in humans.Keywords
This publication has 48 references indexed in Scilit:
- Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndromeBlood, 2009
- Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndromeJCI Insight, 2009
- A DNA-PKcs mutation in a radiosensitive T–B– SCID patient inhibits Artemis activation and nonhomologous end-joiningJCI Insight, 2008
- XLF-Cernunnos promotes DNA ligase IV–XRCC4 re-adenylation following ligationNucleic Acids Research, 2008
- Lymphocyte-Specific Compensation for XLF/Cernunnos End-Joining Functions in V(D)J RecombinationMolecular Cell, 2008
- A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndromeJCI Insight, 2007
- Homeostatically proliferating CD4+ T cells are involved in the pathogenesis of an Omenn syndrome murine modelJCI Insight, 2007
- XLF Interacts with the XRCC4-DNA Ligase IV Complex to Promote DNA Nonhomologous End-JoiningCell, 2006
- Cernunnos, a Novel Nonhomologous End-Joining Factor, Is Mutated in Human Immunodeficiency with MicrocephalyCell, 2006
- Mechanism and regulation of human non-homologous DNA end-joiningNature Reviews Molecular Cell Biology, 2003